Expression of mutant ??-synucleins enhances dopamine transporter-mediated MPP+ toxicity in vitro

Authors:
  • ETEva-Maria Tan
    Eva-Maria Tan
  • JSJohannes Schwarz
    Johannes Schwarz
  • ASAlexander Storch
    Alexander Storch

Abstract
Mutations in the α-synuclein gene (A30P and A53T) are reported to cause familial Parkinson's disease (PD), but it is not known how they result in selective dopaminergic cell death. Here we report on effects of mutant α-synucleins on dopamine transporter (DAT)-mediated toxicity of the selective dopaminergic neurotoxin 1-methyl-4-phenylpyridinium ion (MPP+) in vitro. We established human embryonic kidney HEK-293 cell lines stably co-expressing each α-synuclein isoform and the human DAT. We demonstrate that expression of all α-synuclein isoforms enhances toxicity of general complex I inhibition (rotenone), but only the expression of mutant α-synucleins induces significant increased DAT-dependent toxicity of very low concentrations of MPP+ compared to wild-type protein. Proteasomal inhibition by lactacystin does not alter MPP+-toxicity in all cell lines. Our data suggest a new mechanism of MPP+-induced dopaminergic toxicity by an interaction between mutant α-synucleins and the DAT, which is independent of the function of the proteasome.

This publication has 18 references indexed in Scilit: